Catalyst Pharmaceuticals (CPRX) Depreciation and Depletion (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Depreciation and Depletion came in at $70000.0 in Q1 2026, down 39.13% YoY from $115000.0 in Q1 2025, and down 2.78% on a QoQ basis from $72000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Depreciation and Depletion (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Depreciation and Depletion data on file, last reported at $70000.0 in Q1 2026.
- Quarterly Depreciation and Depletion fell 39.13% year-over-year to $70000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $330000.0 (down 22.54% YoY) and the FY2025 annual result came in at $375000.0, down 5.54% from the prior year.
- Depreciation and Depletion declined to $70000.0 in Q1 2026, from $72000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $116000.0 in Q2 2025 to a low of $34000.0 in Q1 2022.
- A 5-year average of $76411.8 and a median of $81000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion slumped 64.95% — and 2023, when it jumped 140.0%.
- Tracing CPRX's Depreciation and Depletion over 5 years: stood at $35000.0 in 2022, then jumped by 140.0% to $84000.0 in 2023, then jumped by 35.71% to $114000.0 in 2024, then sank by 36.84% to $72000.0 in 2025, then dropped by 2.78% to $70000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $70000.0 (Q1 2026), $72000.0 (Q4 2025), and $72000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |